U of MN research indicates why radiation therapy reduces bone cancer pain
New findings may pave way for improved pain relief methods
Although physicians administer radiation therapy to relieve bone cancer pain in more than 100,000 patients each year in the United States, little is known about why the treatment works. Using an experimental radiation model, University of Minnesota Cancer Center researchers and colleagues have determined that radiation treatment may relieve pain by reducing bone tumor size and decreasing progression of cancer-induced bone destruction. The findings appear in February issue of the journal Radiation Research.
"Perhaps the greatest obstacle to improving pain relief following radiation of bone cancer is our limited knowledge regarding mechanisms responsible for decreasing the pain," said lead investigator Denis Clohisy, M.D., professor of orthopedic surgery in the Medical School and Cancer Center member. "Future use of the experimental system described in this research should help accelerate the pace of discovery around these mechanisms and help efforts to reduce the burden of pain suffered by bone cancer patients."
Researchers in this investigation created an experimental model that limited radiation to the site of cancer in mice and then used an established bone pain model, imaging techniques, and histologic evaluations to understand the effects of radiation.
The research demonstrated that a localized, single radiation dose decreased painful behavior and increased limb use, which was associated with a decrease in bone destruction and tumor burden. Treated mice demonstrated greater pain relief and had significantly less bone destruction and tumor burden than untreated mice. Recent studies have demonstrated that tumor burden and bone destruction each correlate with behavioral and neurochemical measures of pain.
Co-authors of this study are Bruce J. Gerbi, Ph.D., Parham Alaei, Ph.D., Patrick W. Mantyh, J.D., Ph.D., Michael Goblirsch, B.A., Wendy E. Mathews, B.S., and Christine Lynch, B.S.
The Cancer Center at the University of Minnesota is a National Cancer Institute-designated Comprehensive Cancer Center. Awarded more than $80 million in peer-reviewed grants during fiscal year 2003, the Cancer Center conducts cancer research that advances knowledge and enhances care. The center also engages community outreach and public education efforts addressing cancer. To learn more about cancer, visit the University of Minnesota Cancer Center Web site at http://www.cancer.umn.edu. For cancer questions, call the Cancer Center information line at 1-888-CANCER MN (1-888-226-2376) or 612-624-2620 in the metro area.
Molly Portz | EurekAlert!
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
New success for Konstanz physicists in studying the quantum vacuum
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...